4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-23-012595
Chief Executive Officer bought 4,000 shares at $25.37 ($101,479)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Myers Scott Dunseth Chief Executive Officer | 2023-04-12 | Purchase | +4,000 | $25.37 | $101,479 | 259,500 | D |
| Open-market purchases · 4,000 sh · avg $25.37 · $101,479 | |||||||
Loading xslF345X04/ownership.xml…